Michael Roggendorf,Anna-Maria Eis-Hübinger,Jürgen Krauss,Karl Eduard Schneweis,Michaela Arndt,Adalbert Krawczyk,Evelyn Exner,Martin P. Däumer
申请号：
US14543509
公开号：
US09657088B2
申请日:
2014.11.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequence, a hybridoma cell capable of producing the said antibody and the use of the said antibody as a drug, in particular to use for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject as defined in the claims.
